-
Something wrong with this record ?
Galantamine as a preventive of diisopropylphosphorofluoridate toxicity effects in rat brain
MM. Saghafi, M. Živin, P. Pregelj
Language English Country Czech Republic
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Free Medical Journals
from 2000
Freely Accessible Science Journals
from 2000
ProQuest Central
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2000
- MeSH
- Acetylcholinesterase metabolism MeSH
- Fasciculation chemically induced genetics pathology physiopathology MeSH
- Galantamine pharmacology MeSH
- Isoflurophate toxicity MeSH
- Rats MeSH
- RNA, Messenger genetics metabolism MeSH
- Brain drug effects enzymology pathology physiopathology MeSH
- Neuroprotective Agents pharmacology MeSH
- Motor Activity drug effects MeSH
- Movement Disorders genetics pathology physiopathology MeSH
- Rats, Wistar MeSH
- Proto-Oncogene Proteins c-fos genetics metabolism MeSH
- Gene Expression Regulation drug effects MeSH
- Body Temperature drug effects MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Diisopropylfluorophosphate exerts its toxic effect by irreversibly inhibiting acetylcholinesterase. This results in over-stimulation of central and peripheral cholinergic activity. The aim of the present study was to evaluate the possible preventive effects of acute treatment with reversible acetylcholinesterase inhibitor galantamine against the signs of cholinergic toxic syndrome provoked by diisopropylfluorophosphate, such as hypothermia, muscular fasciculations, oral dyskinesia and decreased locomotor performance in a rat model of intoxication. The effects of these two anticholinesterases on acetylcholinesterase activity and on the expression of mRNA of the immediate early response gene c-fos in the brain were assessed by histochemical acetylcholinesterase staining and by in situ hybridization, respectively. Diisopropylfluorophosphate induced rapidly progressing hypothermia, muscular fasciculations, oral dyskinesia and decreased locomotor performance. The increased cholinergic cortical and hippocampal activity due to irreversible acetylcholinerase inhibition were indicated by the increased c-fos mRNA autoradiographic signal and by the inhibition of acetylcholinesterase staining, respectively. Galantamine by itself provoked transient and relatively weak inhibition of the acetylcholinesterase staining, while it did not induce increased c-fos mRNA expression or significant behavioural signs of cholinergic toxicity. Galantamine significantly reduced the rate of the onset, but not the maximal hypothermia induced by diisopropylfluorophosphate. Importantly, all the above-mentioned behavioural and neurochemical effects of diisopropylfluorophosphate were significantly reduced by galantamine. These results indicate that the acute pre-treatment with galantamine may have prophylactic effects against the intoxication by diisopropylfluorophosphate.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14046117
- 003
- CZ-PrNML
- 005
- 20140221072325.0
- 007
- ta
- 008
- 140212s2013 xr da f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)23537526
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Saghafi, M. M. $u University of Ljubljana, Medical Faculty, Institute of Pathophysiology, Brain Research Laboratory, Ljubljana, Slovenia
- 245 10
- $a Galantamine as a preventive of diisopropylphosphorofluoridate toxicity effects in rat brain / $c MM. Saghafi, M. Živin, P. Pregelj
- 520 9_
- $a Diisopropylfluorophosphate exerts its toxic effect by irreversibly inhibiting acetylcholinesterase. This results in over-stimulation of central and peripheral cholinergic activity. The aim of the present study was to evaluate the possible preventive effects of acute treatment with reversible acetylcholinesterase inhibitor galantamine against the signs of cholinergic toxic syndrome provoked by diisopropylfluorophosphate, such as hypothermia, muscular fasciculations, oral dyskinesia and decreased locomotor performance in a rat model of intoxication. The effects of these two anticholinesterases on acetylcholinesterase activity and on the expression of mRNA of the immediate early response gene c-fos in the brain were assessed by histochemical acetylcholinesterase staining and by in situ hybridization, respectively. Diisopropylfluorophosphate induced rapidly progressing hypothermia, muscular fasciculations, oral dyskinesia and decreased locomotor performance. The increased cholinergic cortical and hippocampal activity due to irreversible acetylcholinerase inhibition were indicated by the increased c-fos mRNA autoradiographic signal and by the inhibition of acetylcholinesterase staining, respectively. Galantamine by itself provoked transient and relatively weak inhibition of the acetylcholinesterase staining, while it did not induce increased c-fos mRNA expression or significant behavioural signs of cholinergic toxicity. Galantamine significantly reduced the rate of the onset, but not the maximal hypothermia induced by diisopropylfluorophosphate. Importantly, all the above-mentioned behavioural and neurochemical effects of diisopropylfluorophosphate were significantly reduced by galantamine. These results indicate that the acute pre-treatment with galantamine may have prophylactic effects against the intoxication by diisopropylfluorophosphate.
- 650 _2
- $a acetylcholinesterasa $x metabolismus $7 D000110
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a tělesná teplota $x účinky léků $7 D001831
- 650 _2
- $a mozek $x účinky léků $x enzymologie $x patologie $x patofyziologie $7 D001921
- 650 _2
- $a fascikulace $x chemicky indukované $x genetika $x patologie $x patofyziologie $7 D005207
- 650 _2
- $a galantamin $x farmakologie $7 D005702
- 650 _2
- $a regulace genové exprese $x účinky léků $7 D005786
- 650 _2
- $a isofluorofát $x toxicita $7 D007531
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a pohybová aktivita $x účinky léků $7 D009043
- 650 _2
- $a pohybové poruchy $x genetika $x patologie $x patofyziologie $7 D009069
- 650 _2
- $a neuroprotektivní látky $x farmakologie $7 D018696
- 650 _2
- $a protoonkogenní proteiny c-fos $x genetika $x metabolismus $7 D016760
- 650 _2
- $a messenger RNA $x genetika $x metabolismus $7 D012333
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Živin, M. $u University of Ljubljana, Medical Faculty, Institute of Pathophysiology, Brain Research Laboratory, Ljubljana, Slovenia
- 700 1_
- $a Pregelj, P. $u University of Ljubljana, Medical Faculty, Institute of Pathophysiology, Brain Research Laboratory, Ljubljana, Slovenia
- 773 0_
- $w MED00011004 $t Folia biologica $x 0015-5500 $g Roč. 59, č. 1 (2013), s. 32-40
- 856 41
- $u https://fb.cuni.cz/file/5669/FB2013A0004.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 970 $c 89 $y 4 $z 0
- 990 __
- $a 20140212 $b ABA008
- 991 __
- $a 20140214141937 $b ABA008
- 999 __
- $a ok $b bmc $g 1013821 $s 844651
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 59 $c 1 $d 32-40 $i 0015-5500 $m Folia biologica (Praha) $n Folia biol. (Praha) $x MED00011004
- LZP __
- $b NLK138 $a Pubmed-20140212